
US Loses Measles Elimination Status After 26 Years
Key Takeaways
- PAHO re-verified that uninterrupted circulation of the same measles genotype/lineage for ≥12 months constitutes reestablished endemic transmission, resulting in elimination-status loss for the US, Mexico, and Bolivia.
- US measles burden reached 5412 confirmed cases in 2026 by November 12, with the Americas reporting 58,213 cases and 82 deaths, signaling broad regional resurgence.
PAHO confirmed endemic measles transmission in the US, Mexico, and Bolivia, putting pharmacists' role in vaccination and case detection in focus.
The Pan American Health Organization (PAHO) announced on November 17, 2026, that endemic measles transmission has been reestablished in the United States, Mexico, and Bolivia, and all 3 countries have lost their measles elimination status.
The decision raises the stakes for pharmacists, whose walk-in access and extended hours make them an accessible point of care for both measles-mumps-rubella (MMR)
The determination followed a November 10-13 meeting of PAHO's Measles, Rubella, and Congenital Rubella Syndrome Elimination Regional Monitoring and Re-Verification Commission. Under the commission's criteria, endemic transmission is reestablished when the same measles virus genotype and lineage circulate uninterrupted for 12 months or more in a country. The US achieved elimination status in 2000, and Canada lost its status in November 2025.
"This is a serious warning for our region, but it is not an irreversible setback," PAHO Director Jarbas Barbosa said in the release.1,2
US Cases Reach Multidecade High
As of November 12, the CDC had reported 5412 confirmed measles cases in the US in 2026, about 2.4 times the 2289 cases reported in all of 2025. Across the Americas, PAHO reported 58,213 confirmed cases and 82 deaths as of November 13, compared with 12,806 cases during the same period last year.1,3
In August, Pennsylvania confirmed 2 measles-associated deaths in unvaccinated residents, the state's first in 35 years. National kindergarten MMR coverage has declined from 95.2% in the 2019-2020 school year to 92.4% in 2025-2026, below the community immunity threshold of above 95% coverage.4
CDC Pledges Push to Regain Status
In a joint statement with public health partners, the CDC said it will work to stop outbreaks and regain elimination status by promoting MMR vaccination, expanding vaccine access, equipping health departments, and strengthening data sharing and outbreak response. The agency said it has provided approximately $100 million in additional funding nationwide since August.
"The measles elimination designation is not what protects Americans. Vaccination does," said CDC Director Erica Schwartz, MD. According to the statement, HHS Secretary Robert F. Kennedy Jr. and Schwartz continue to recommend MMR vaccination as the most effective way to prevent measles, and Barbosa commended US efforts to manage the outbreak.2,4
Closing Immunity Gaps at the Pharmacy
Two doses of MMR vaccine provide approximately 97% protection against measles. "For herd immunity—or community immunity—we generally look for about a 95% vaccination rate," Crystal Hodge, PharmD, BCIDP, BCPS, said in a previous interview with Pharmacy Times.5
Jeff Goad, PharmD, MPH, professor of pharmacy practice at Chapman University School of Pharmacy, has noted that pharmacists can identify vaccination gaps during routine visits, medication therapy management, and travel consultations, particularly among international travelers, health care workers, college students, and parents of infants. Scope of practice and age limits for pharmacist-administered MMR vaccination vary by state. The CDC recommends an early MMR dose at 6 months for infants living in or traveling to outbreak areas, followed by standard doses at 12 to 15 months and 4 to 6 years.4,7,9
Early timing matters. Children who received their 2-month vaccines late had 7 times the odds of missing MMR vaccination at 2 years, according to research from Nina Masters, PhD, MPH, an epidemiologist at Truveta. "Pharmacists can engage parents of young children to address questions or encourage follow-up with their pediatricians.”6
Recognizing Cases and Countering Hesitancy
Goad said pharmacists should recognize the measles prodrome of cough, coryza, and conjunctivitis. When measles is suspected, pharmacists should limit exposure, such as by asking the patient to wear a mask and directing them to care, and call ahead to the emergency department or urgent care center. PAHO also recommends protecting health workers by verifying vaccination status and using airborne isolation protocols.1,7
For hesitancy, Pediatric Pharmacy Association recommendations highlight motivational interviewing and "prebunking," or training patients to recognize misinformation before they encounter it. Pharmacists may also field questions about an August 2026 executive order recommending that MMR be split into 3 single-disease shots "once such products are domestically available."8,9
PAHO said sustaining at least 95% coverage with both measles vaccine doses in every community remains essential. "Elimination is not a trophy that we win once and put on a shelf," Barbosa said.1
REFERENCES
1. PAHO urges countries to step up efforts to stop measles outbreaks and move towards elimination in the Americas. News release. Pan American Health Organization. November 17, 2026. Accessed November 17, 2026. https://www.paho.org/en/news/17-11-2026-paho-urges-countries-step-efforts-stop-measles-outbreaks-and-move-towards
2. Joint statement: loss of U.S. measles elimination status. News release. CDC. November 17, 2026. Accessed November 17, 2026. https://www.cdc.gov/media/releases/2026/loss-of-usmeasles-elimination-status.html
3. Measles update: November 13, 2026. ContagionLive. November 13, 2026. Accessed November 17, 2026. https://www.contagionlive.com/view/measles-update-november-13-2026
4. Ferruggia K. Pennsylvania confirms first measles deaths in 35 years as US case count tops 2900. Pharmacy Times. September 1, 2026. Accessed November 17, 2026. https://www.pharmacytimes.com/view/pennsylvania-confirms-first-measles-deaths-in-35-years-as-us-case-count-tops-2900
5. Gerlach A. US measles cases climb, raising questions about preparedness and prevention. Pharmacy Times. December 16, 2025. Accessed November 17, 2026. https://www.pharmacytimes.com/view/us-measles-cases-climb-raising-questions-about-preparedness-and-prevention
6. Masters N, Halpern L. Q&A: How pharmacists can help prevent missed MMR vaccinations in children. Pharmacy Times. January 16, 2026. Accessed November 17, 2026. https://www.pharmacytimes.com/view/q-a-how-pharmacists-can-help-prevent-missed-mmr-vaccinations-in-children
7. Kariyawasam-Chavez R, Goad J. Pharmacists' role in measles outbreak response amid rising cases. Pharmacy Times. May 21, 2026. Accessed November 17, 2026. https://www.pharmacytimes.com/view/pharmacists-role-in-measles-outbreak-response-amid-rising-cases
8. Belcourt J. How pharmacists can combat vaccine hesitancy and protect children from measles outbreaks. Pharmacy Times. February 18, 2026. Accessed November 17, 2026. https://www.pharmacytimes.com/view/how-pharmacists-can-combat-vaccine-hesitancy-and-protect-children-from-measles-outbreaks
9. Halpern L. Trump executive order recommends separating MMR into 3 shots. Pharmacy Times. August 10, 2026. Accessed November 17, 2026. https://www.pharmacytimes.com/view/trump-executive-order-recommends-separating-mmr-into-3-shots
Related to this article








